Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
How would you treat a patient with a post prostatectomy biochemical and pelvic nodal recurrence with a BLM mutation?
Related Questions
What is your preferred approach in a patient unable to fill their bladder during prostate radiotherapy?
How would you manage incidentally-found prostate cancer on TURP?
How would you treat an isolated urothelial cancer local recurrence abutting the duodenum?
How do you approach Lu-177 use in taxane-naive patients with metastatic prostate cancer?
Is there any evidence for combining surgery and XRT +/- ADT for treatment of localized high risk prostate cancer?
Do you utilize daily enemas for patients undergoing prostate SBRT?
How would you manage a patient who developed an intraprostatic abscess after SpaceOAR injection, prior to starting radiation?
How do you follow/manage patients with metastatic prostate cancer with undetectable PSA and castration-sensitive but active disease on PSMA PET?
As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?
How would you optimally boost patients with high or very high risk prostate cancer receiving definitive radiotherapy in 2025?
